EpiPen^® (adrenaline 300micrograms/0.3millilitres) and EpiPen^® Jr (adrenaline 150 micrograms/0.3millilitres) Auto-Injector. Restricted Medicine. Indications: For the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, medications or other allergens. Contraindications: Arrhythmias, cerebral arteriosclerosis; maternal hypertension in excess of 130/80; shock (other than anaphylactic shock), organic brain damage, or during general anaesthesia with halogenated hydrocarbons or cyclopropane, and in patients where vasopressor drugs are contraindicated. Precautions: Patients with heart diseases, allergies to sulphites, cardiac dilation, ventricular fibrillation, cerebral arteriosclerosis, coronary insufficiency, prefibrillatory rhythm, tachycardia, myocardial infarction, phenothiazine-induced circulatory collapse, prostatic hypertrophy, elderly, diabetes, hypertension, organic brain damage, narrow angle glaucoma, hyperthyroidism, psychoneurosis, patients with Parkinsonism, asthmatic children, serious skin and soft tissue infections, laceration and embedded needles reported at injection site. Interactions: Concomitant use with tricyclic antidepressants, thyroid medicines and hormones, monoamine oxidase inhibitors, diphenhydramine, dexchlorpheniramine, chlorpheniramine, tripelennamine, sympathomimetic agents, alpha-adrenergic blocking agents, beta-adrenergic blocking agents, general anaesthetics, hypoglycaemic agents not advised or advised with caution. See datasheet for more information and incompatibilities. Common Adverse Effects: Tachycardia, respiratory difficulty, sweating, pallor, nausea, vomiting, sleeplessness, hallucinations, palpitations, redness of face and skin, psychomotor agitation, impaired memory. Potentially fatal ventricular arrhythmias, including ventricular fibrillation may occur and severe hypertension may lead to cerebral haemorrhage and pulmonary oedema. Dosage & Administration: EpiPen^® delivers a single 300micrograms intramuscular dose of adrenaline and should only be used in patients weighing more than 30kg. EpiPen^® Jr delivers a single 150micrograms intramuscular dose of adrenaline and should only be used in children weighing 15kg to 30kg. EpiPen^® and EpiPen^® Jr are non-funded medicines. Patients are required to pay the full cost. Before recommending this medicine please refer to full datasheet available from: www.medsafe.govt.nz. EpiPen^® is a registered trademark of Mylan Inc. Mylan NZ Ltd., Auckland. TAPS DA1826FR-261.